A robust and reliably detectable HIF-1 activation was shown (i) ex vivo in biopsies of patients suffering from skin infections, (ii) in vitro using cell culture infection models and (iii) in vivo using murine S. aureus infection models. This evidence concerns the gene SETD2 and infection.